Thoma Bravo Invests in Bluesight to Support Bluesight's Acquisition of Medacist
July 17, 2023
Thoma Bravo made a strategic growth investment in Bluesight to support Bluesight's acquisition of Medacist, combining two medication-management and drug-diversion analytics businesses into a single hospital pharmacy software platform. The combined company will expand Bluesight's medication intelligence capabilities and serve more than 2,000 hospitals across North America; committed financing was led by Monroe Capital and existing investor New Leaf Ventures remains invested. Financial terms were not disclosed.
- Buyers
- Thoma Bravo, Bluesight, Monroe Capital LLC
- Targets
- Medacist
- Platforms
- Bluesight
- Industry
- Healthcare Services
- Location
- Connecticut, United States
- Transaction Type
- Addon
Explore More
Related Acquisitions
-
Bluesight Acquires Protenus to Expand Healthcare Compliance Capabilities
January 9, 2025
Healthcare Services
Bluesight, a provider of inventory management, procurement, and compliance solutions for hospitals, has acquired Protenus, a Baltimore-based healthcare compliance analytics platform. The acquisition expands Bluesight's drug diversion and patient privacy monitoring capabilities, combining AI-driven compliance analytics with Bluesight's hospital and pharmacy operations intelligence.
-
Bluesight Acquires Sectyr
October 17, 2024
Healthcare Services
Bluesight, a provider of Medication Intelligence solutions, has acquired Sectyr, a cloud-based compliance and audit management platform focused on 340B program management. The acquisition adds 340B audit and compliance capabilities to Bluesight’s product suite to improve pharmacy compliance, audit readiness, and operational visibility for hospitals and health systems.
-
Thoma Bravo Makes Strategic Growth Investment in BlueMatrix
December 14, 2023
Cloud & SaaS
Thoma Bravo has completed a strategic growth investment in BlueMatrix, a cloud-based content creation and distribution platform for investment research providers. The investment (debt financing provided by Golub Capital) will support BlueMatrix’s global growth and continued product innovation while founder and CEO Patricia Horotan remains in her leadership role with a significant ownership stake.
-
Thoma Bravo Makes Strategic Investment in Grayshift
June 21, 2022
Cybersecurity
Thoma Bravo has completed a strategic growth investment in Grayshift, a U.S.-based provider of mobile device digital forensics solutions. The capital will support Grayshift’s product innovation, international expansion, and potential strategic acquisitions; existing investors PeakEquity Partners and C&B Capital will remain shareholders.
-
Thoma Bravo Makes Majority Strategic Investment in Azul
November 18, 2025
Cloud & SaaS
Azul, a Java-focused enterprise software company, entered into a definitive agreement to receive a majority strategic investment from Thoma Bravo. Existing investors Vitruvian Partners and Lead Edge Capital will reinvest and retain minority stakes alongside Azul employees.
-
Thoma Bravo Acquires NextGen Healthcare
November 10, 2023
Cloud & SaaS
Thoma Bravo, a leading software-focused private equity firm, has completed the acquisition of NextGen Healthcare, Inc. for $1.8 billion, taking the company private at $23.95 per share. The transaction (previously announced Sept. 6, 2023) will delist NextGen from Nasdaq and aims to accelerate product innovation and growth across NextGen's cloud-based ambulatory healthcare technology offerings.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.